CompletedPhase 2NCT00725439

An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stiefel, a GSK Company
Principal Investigator
Prof. Dr. D. Roseeuw, MD
Department Dermatology, University Hospital Brussel (UZ Brussel)
Intervention
Talarozole(drug)
Enrollment
16 enrolled
Eligibility
16-50 years · MALE
Timeline
20042007

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00725439 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials